Upgrade to SI Premium - Free Trial

Myriad Genetics (MYGN)

5.66 -0.25 (4.23%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Myriad Genetics launches four-in-one prenatal genetic screen July 21, 2026 9:05 AM - StreetInsider Myriad Genetics Launches FirstGene® Multiple Prenatal Screen July 21, 2026 9:05 AM - StreetInsider New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate Cancer July 2, 2026 9:05 AM - StreetInsider Form 4 MYRIAD GENETICS INC For: Jun 23 Filed by: Skovronsky Daniel June 23, 2026 4:25 PM - SEC Filing Myriad Genetics expands Precise MRD cancer test to three tumor types June 23, 2026 9:05 AM - StreetInsider Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication June 23, 2026 9:05 AM - StreetInsider Myriad Genetics board member Skovronsky resigns June 23, 2026 8:36 AM - StreetInsider Form 8-K MYRIAD GENETICS INC For: Jun 17 June 23, 2026 8:32 AM - SEC Filing Form 4 MYRIAD GENETICS INC For: Jun 11 Filed by: Raha Samraat S. June 12, 2026 6:06 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Jun 11 Filed by: Donnelly Brian J June 12, 2026 6:06 PM - SEC Filing TD Cowen notes short interest shifts in life science tools stocks June 10, 2026 10:50 AM - StreetInsider Form 4 MYRIAD GENETICS INC For: Jun 08 Filed by: Kumar Rashmi June 9, 2026 4:21 PM - SEC Filing Form 144 MYRIAD GENETICS INC Filed by: Kumar Rashmi June 8, 2026 11:17 AM - SEC Filing Form 4 MYRIAD GENETICS INC For: Jun 04 Filed by: Skovronsky Daniel June 5, 2026 4:26 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Jun 04 Filed by: Newcomer Lee Nisley June 5, 2026 4:25 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Jun 04 Filed by: Davis Mark Steven June 5, 2026 4:25 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Jun 04 Filed by: Phanstiel S. Louise June 5, 2026 4:25 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Jun 04 Filed by: Reitan Colleen F June 5, 2026 4:25 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Jun 04 Filed by: Dreismann Heinrich June 5, 2026 4:25 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Jun 04 Filed by: Kumar Rashmi June 5, 2026 4:25 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Jun 04 Filed by: Bisaro Paul June 5, 2026 4:25 PM - SEC Filing Form 8-K MYRIAD GENETICS INC For: Jun 04 June 4, 2026 4:09 PM - SEC Filing Form S-8 MYRIAD GENETICS INC June 4, 2026 4:08 PM - SEC Filing Form S-8 MYRIAD GENETICS INC June 4, 2026 4:06 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Jun 01 Filed by: Jampa Raj June 2, 2026 4:21 PM - SEC Filing Form 3 MYRIAD GENETICS INC For: Jun 01 Filed by: Jampa Raj June 2, 2026 4:15 PM - SEC Filing Myriad Genetics names Raj Jampa as chief technology officer June 2, 2026 9:05 AM - StreetInsider Myriad Genetics Names Raj Jampa as New Chief Technology Officer June 2, 2026 9:05 AM - StreetInsider Myriad Genetics Highlights Data Showing Broad Clinical Utility of Precise MRD Assay at 2026 ASCO Annual Meeting May 27, 2026 9:05 AM - StreetInsider Myriad Genetics launches Prolaris + AI prostate cancer test May 26, 2026 4:06 PM - StreetInsider Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI) May 26, 2026 4:05 PM - StreetInsider Actress Jackie Tohn Got Results Nobody Wants But They May Have Saved Her Life May 15, 2026 11:00 AM - Globe NewsWire Form 4 MYRIAD GENETICS INC For: May 14 Filed by: Bisaro Paul May 14, 2026 5:17 PM - SEC Filing Form SCHEDULE 13G MYRIAD GENETICS INC Filed by: STATE STREET CORP May 12, 2026 11:38 AM - SEC Filing Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences May 7, 2026 4:05 PM - StreetInsider Myriad Genetics (MYGN) PT Lowered to $10 at Craig-Hallum May 6, 2026 9:35 AM - StreetInsider Myriad Genetics (MYGN) PT Lowered to $5.50 at Wells Fargo May 6, 2026 8:49 AM - StreetInsider Myriad Genetics (MYGN) PT Lowered to $6 at TD Cowen May 6, 2026 8:20 AM - StreetInsider Form 10-Q MYRIAD GENETICS INC For: Mar 31 May 6, 2026 6:08 AM - SEC Filing Myriad Genetics (MYGN) Misses Q1 EPS by 2c ; Offers Guidance May 6, 2026 2:50 AM - StreetInsider Form 8-K MYRIAD GENETICS INC For: May 05 May 5, 2026 4:09 PM - SEC Filing Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business May 5, 2026 4:05 PM - StreetInsider Form 4 MYRIAD GENETICS INC For: May 01 Filed by: Donnelly Brian J May 4, 2026 4:36 PM - SEC Filing Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan April 30, 2026 9:05 AM - Globe NewsWire Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026 April 28, 2026 4:05 PM - StreetInsider Full Article List